Active Ingredient: ZILEUTON
Proprietary Name: ZILEUTON
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: 600MG
Reference Listed Drug: No
Reference Standard: Yes
TE Code: AB
Application Number: A204929
Product Number: 001
Approval Date: Mar 17, 2017
Applicant Holder Full Name: RISING PHARMA HOLDINGS INC
Marketing Status:
Prescription
Patent and Exclusivity Information
